Summary

According to Triton Market Research’s report, the Global Eyelid Surgery Blepharoplasty Market is likely to grow with a CAGR of 6.46% in the forecast period 2024-2032.
GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET ANALYSIS
Eyelid surgery blepharoplasty is a common cosmetic procedure aimed at improving the appearance of the eyelids. The blepharoplasty procedure can involve upper eyelid surgery, lower eyelid surgery, or both, depending on the patient’s needs. The primary goal is to remove excess skin, muscle, or fat that can cause drooping or puffiness around the eyes, contributing to a more youthful and refreshed appearance. Various factors, including the rising geriatric population and the demand for eyelid rejuvenation, drive the demand for blepharoplasty. This procedure can also address functional concerns, such as impaired vision due to drooping eyelids. This market has seen a significant increase in demand for non-invasive surgical procedures and minimally invasive surgical treatments, reflecting a broader trend within the cosmetic surgery industry.
The eyelid surgery blepharoplasty market is segmented by procedure type, including double eyelid surgery, and by end-use and service provider categories. Traditional surgical techniques remain prevalent, but there is a growing interest in less invasive options as patients seek procedures with shorter recovery times and lower risks. The eyelid surgery blepharoplasty cost can vary depending on factors like the complexity of the eyelid surgery procedure and the expertise of the surgeon. As the demand for cosmetic surgery continues to rise, particularly in regions with a high population of older adults, the blepharoplasty industry is expected to grow. This growth is also fueled by advancements in surgical techniques and increasing awareness of the benefits of blepharoplasty surgery procedures. Thus, the demand for blepharoplasty procedures is likely to continue expanding as more individuals seek to enhance their appearance and address aging concerns.
EYELID SURGERY BLEPHAROPLASTY MARKET PERFORMANCE: DRIVERS, CHALLENGES, AND OPPORTUNITIES
Increasing Prevalence of Eye Conditions
Eyelid surgery or blepharoplasty is becoming increasingly common due to the rising prevalence of eye conditions that can affect both appearance and function. Factors such as aging, genetic predispositions, and lifestyle choices contribute to issues like droopy eyelids, under-eye bags, and vision impairment. According to the American Academy of Ophthalmology, nearly 3.2 million people in the US suffer from ptosis, a condition where the upper eyelid droops over the eye. Moreover, the National Institute on Aging notes that around 20% of people over the age of 65 experience significant eyelid changes that may require surgical intervention. Blepharoplasty is opted for aesthetic reasons as well as to improve peripheral vision, which can be obstructed by sagging eyelids. This surgery addresses both functional and cosmetic concerns, making it a relevant procedure in the context of an aging population and increasing eye health issues.
High Costs and Limited Insurance Coverage
Despite the benefits of eyelid surgery (blepharoplasty), there are significant restraints due to the high costs and limited insurance coverage associated with the procedure. Blepharoplasty can range in cost from $3,000 to $6,000 depending on the complexity and location, making it a substantial financial commitment for many individuals. Additionally, insurance companies typically classify blepharoplasty as a cosmetic procedure, resulting in limited or no coverage unless the surgery is deemed medically necessary to correct vision impairment. The American Society of Plastic Surgeons notes that only a small percentage of eyelid surgeries qualify for insurance reimbursement under strict criteria, such as documented evidence of vision obstruction. This financial barrier can prevent many potential patients from pursuing the surgery, limiting access primarily to those who can afford to pay out-of-pocket. The high costs and restricted insurance support thus serve as significant deterrents for individuals considering blepharoplasty.
Fractional Non-Ablative Laser Technology
Fractional non-ablative laser technology offers an alternative to traditional eyelid surgery blepharoplasty for eye rejuvenation. This method targets deeper skin layers with laser energy, stimulating collagen production and improving skin texture and elasticity without damaging the surface. Unlike surgical options, this technology provides a less invasive treatment with reduced downtime and fewer complications, making it suitable for patients seeking cosmetic enhancements around the eyes. As the technology evolves, it could become a more accessible and widely used option, appealing to those who prefer non-surgical treatments for skin rejuvenation.


GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET SEGMENTATION ANALYSIS
• Market by Gender:
o Male
o Female
The male segment of the global eyelid surgery blepharoplasty market has experienced steady growth in recent years, driven by the increasing social acceptance and availability of aesthetic procedures for men. This trend is supported by targeted marketing efforts and rising disposable incomes among the key 35-60-year-old demographic, enabling more spending on elective surgeries. Male baby boomers have also shown significant growth in this market, as longer life expectancies encourage investment in treatments aimed at maintaining a youthful appearance. Additionally, advancements in technology have made eyelid procedures more efficient, less painful, and more accessible, contributing to their growing popularity.
• Market by Procedure Type:
o Lower Eyelid Blepharoplasty
o Upper Eyelid Blepharoplasty
o Combination Eyelid Surgery
Lower eyelid blepharoplasty is increasingly being sought after worldwide as a procedure to address bagginess, wrinkles, and dark circles under the eyes. As skin loses elasticity over time, the lower eyelid area can droop or wrinkle, and fat can migrate, creating under-eye bags that contribute to a tired, aged appearance. Lower blepharoplasty aims to remove or reposition this excess fat and skin, providing a more refreshed appearance. The transconjunctival approach to lower blepharoplasty, which accesses fat deposits through the inside of the eyelid and leaves no visible scarring, has seen growing adoption due to its minimally invasive nature and quick recovery despite higher costs per procedure. Additionally, laser-assisted lower blepharoplasty offers the benefits of enhanced skin tightening and coagulation with smaller incisions.
• Market by Product Type:
o Laser Instrument
o Laser Shield
o Surgical Instrument
• Market by End-User:
o Hospital
o Clinics
o Ambulatory Surgical Centre
MARKET BY REGION:
• North America: United States and Canada,
• Europe: United Kingdom, Germany, France, Spain, Italy, Poland, and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand, and Rest of Asia Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East & Africa: United Arab Emirates, Saudi Arabia, Israel, South Africa, and Rest of Middle East & Africa
KEY EYELID SURGERY BLEPHAROPLASTY COMPANIES INSIGHTS

The companies’ insights help dive into data about the key players in the eyelid surgery blepharoplasty market. The strategic initiatives for each of the companies considered have been covered in detail. Some of the key strategic initiatives are:

Innovation (September 2020): Galderma
In September 2020, Galderma announced the launch of its new Restylane Refyne and Restylane Defyne, two hyaluronic acid-based dermal fillers.
Acquisition (October 2020): Allergan Aesthetics and Luminera
In October 2020, Allergan Aesthetics, an AbbVie company, agreed with Luminera, a privately held aesthetics company with a portfolio and pipeline of dermal filler products. This agreement will enhance the dermal filler portfolio of the company in international and US markets.
Partnership (July 2020): Galderma and Revance Therapeutics Inc
In July 2020, Galderma and Revance Therapeutics, Inc. announced a strategic collaboration to develop and commercialize a portfolio of aesthetic treatments.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. PORTER’S FIVE FORCES ANALYSIS
2.1.1. THREAT OF NEW ENTRANTS
2.1.2. THREAT OF SUBSTITUTES
2.1.3. BARGAINING POWER OF BUYERS
2.1.4. BARGAINING POWER OF SUPPLIERS
2.1.5. THREAT OF COMPETITIVE RIVALRY
2.2. MARKET MATURITY ANALYSIS
2.3. SUPPLY CHAIN ANALYSIS
2.3.1. RAW MATERIALS
2.3.2. MANUFACTURERS
2.3.3. DISTRIBUTORS
2.3.4. END USER
2.4. REGULATORY FRAMEWORK
2.5. KEY BUYING IMPACT ANALYSIS
2.5.1. BIOCOMPATIBILITY
2.5.2. DURABILITY AND LONGEVITY
2.5.3. CUSTOMIZATION AND VERSATILITY
2.5.4. REGULATORY COMPLIANCE AND QUALITY ASSURANCE
2.6. KEY MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT LAUNCHES
2.6.3. ACQUISITIONS
2.6.4. BUSINESS DIVESTITURES & EXPANSIONS
2.7. MARKET DRIVERS
2.7.1. INCREASING PREVALENCE OF EYE CONDITIONS
2.7.2. ENHANCED AWARENESS OF COSMETIC BENEFITS
2.7.3. ADVANCEMENTS IN SURGICAL TECHNOLOGY
2.7.4. IMPROVED INFRASTRUCTURE AND ACCESSIBILITY
2.8. MARKET CHALLENGES
2.8.1. HIGH COSTS AND LIMITED INSURANCE COVERAGE
2.8.2. AVAILABILITY OF NON-SURGICAL ALTERNATIVES
2.8.3. SHORTAGE OF SKILLED SURGEONS IN DEVELOPING AREAS
2.9. MARKET OPPORTUNITIES
2.9.1. LESS INVASIVE TECHNIQUES
2.9.2. FRACTIONAL NON-ABLATIVE LASER TECHNOLOGY
2.10. ANALYST PERSPECTIVE
3. GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET – BY GENDER
3.1. MALE
3.2. FEMALE
4. GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET – BY PROCEDURE TYPE
4.1. UPPER EYELID BLEPHAROPLASTY
4.2. COMBINATION EYELID SURGERY
4.3. LOWER EYELID BLEPHAROPLASTY
5. GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET – BY PRODUCT TYPE
5.1. LASER SHIELD
5.2. LASER INSTRUMENT
5.3. SURGICAL INSTRUMENT
6. GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET – BY END-USER
6.1. HOSPITAL
6.2. CLINICS
6.3. AMBULATORY SURGICAL CENTRE
7. GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET – BY REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. MARKET BY GENDER
7.1.2. MARKET BY PROCEDURE TYPE
7.1.3. MARKET BY PRODUCT TYPE
7.1.4. MARKET BY END-USER
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.1.1. UNITED STATES EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.1.5.2. CANADA
7.1.5.2.1. CANADA EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.2. EUROPE
7.2.1. MARKET BY GENDER
7.2.2. MARKET BY PROCEDURE TYPE
7.2.3. MARKET BY PRODUCT TYPE
7.2.4. MARKET BY END-USER
7.2.5. COUNTRY ANALYSIS
7.2.5.1. UNITED KINGDOM
7.2.5.1.1. UNITED KINGDOM EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.2.5.2. GERMANY
7.2.5.2.1. GERMANY EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.2.5.3. FRANCE
7.2.5.3.1. FRANCE EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.2.5.4. SPAIN
7.2.5.4.1. SPAIN EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.2.5.5. ITALY
7.2.5.5.1. ITALY EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.2.5.6. POLAND
7.2.5.6.1. POLAND EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.2.5.7. REST OF EUROPE
7.2.5.7.1. REST OF EUROPE EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.3. ASIA-PACIFIC
7.3.1. MARKET BY GENDER
7.3.2. MARKET BY PROCEDURE TYPE
7.3.3. MARKET BY PRODUCT TYPE
7.3.4. MARKET BY END-USER
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.1.1. CHINA EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.3.5.2. JAPAN
7.3.5.2.1. JAPAN EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.3.5.3. INDIA
7.3.5.3.1. INDIA EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.3.5.4. SOUTH KOREA
7.3.5.4.1. SOUTH KOREA EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.3.5.5. ASEAN COUNTRIES
7.3.5.5.1. ASEAN COUNTRIES EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.3.5.6. AUSTRALIA & NEW ZEALAND
7.3.5.6.1. AUSTRALIA & NEW ZEALAND EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.3.5.7. REST OF ASIA-PACIFIC
7.3.5.7.1. REST OF ASIA-PACIFIC EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.4. LATIN AMERICA
7.4.1. MARKET BY GENDER
7.4.2. MARKET BY PROCEDURE TYPE
7.4.3. MARKET BY PRODUCT TYPE
7.4.4. MARKET BY END-USER
7.4.5. COUNTRY ANALYSIS
7.4.5.1. BRAZIL
7.4.5.1.1. BRAZIL EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.4.5.2. MEXICO
7.4.5.2.1. MEXICO EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.4.5.3. REST OF LATIN AMERICA
7.4.5.3.1. REST OF LATIN AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.5. MIDDLE EAST AND AFRICA
7.5.1. MARKET BY GENDER
7.5.2. MARKET BY PROCEDURE TYPE
7.5.3. MARKET BY PRODUCT TYPE
7.5.4. MARKET BY END-USER
7.5.5. COUNTRY ANALYSIS
7.5.5.1. UNITED ARAB EMIRATES
7.5.5.1.1. UNITED ARAB EMIRATES EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.5.5.2. SAUDI ARABIA
7.5.5.2.1. SAUDI ARABIA EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.5.5.3. ISRAEL
7.5.5.3.1. ISRAEL EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.5.5.4. SOUTH AFRICA
7.5.5.4.1. SOUTH AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
7.5.5.5. REST OF MIDDLE EAST & AFRICA
7.5.5.5.1. REST OF MIDDLE EAST & AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET FORECAST & PROSPECTS
8. COMPETITIVE LANDSCAPE
8.1. BOMTECH ELECTRONICS CO LTD
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY STRENGTHS
8.1.4. KEY CHALLENGE
8.2. CYNOSURE INC
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY STRENGTHS
8.2.4. KEY CHALLENGE
8.3. GRAND AESPIO INC
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY STRENGTH
8.3.4. KEY CHALLENGE
8.4. IOPTIMA
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY STRENGTHS
8.4.4. KEY CHALLENGE
8.5. LIGHTSCALPEL
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY STRENGTHS
8.5.4. KEY CHALLENGES
8.6. LONDON BRIDGE PLASTIC SURGERY
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY STRENGTHS
8.6.4. KEY CHALLENGE
8.7. OSHERU LLC
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY STRENGTHS
8.7.4. KEY CHALLENGES
8.8. SCITON INC
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY STRENGTHS
8.8.4. KEY CHALLENGES
8.9. SISRAM MEDICAL LTD.
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY STRENGTHS
8.9.4. KEY CHALLENGES
8.10. SURGICAL HOLDINGS
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY STRENGTHS
8.10.4. KEY CHALLENGE
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY



LIST OF TABLES:
TABLE 1: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 2: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF COLLABORATIONS
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 8: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY GENDER, 2024-2032 (IN $ MILLION)
TABLE 9: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY PROCEDURE TYPE, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY PRODUCT TYPE, 2024-2032 (IN $ MILLION)
TABLE 11: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY END-USER, 2024-2032 (IN $ MILLION)
TABLE 12: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 13: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: NORTH AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 15: NORTH AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY GENDER, 2024-2032 (IN $ MILLION)
TABLE 16: NORTH AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY PROCEDURE TYPE, 2024-2032 (IN $ MILLION)
TABLE 17: NORTH AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY PRODUCT TYPE, 2024-2032 (IN $ MILLION)
TABLE 18: NORTH AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY END-USER, 2024-2032 (IN $ MILLION)
TABLE 19: EUROPE EYELID SURGERY BLEPHAROPLASTY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 20: EUROPE EYELID SURGERY BLEPHAROPLASTY MARKET, BY GENDER, 2024-2032 (IN $ MILLION)
TABLE 21: EUROPE EYELID SURGERY BLEPHAROPLASTY MARKET, BY PROCEDURE TYPE, 2024-2032 (IN $ MILLION)
TABLE 22: EUROPE EYELID SURGERY BLEPHAROPLASTY MARKET, BY PRODUCT TYPE, 2024-2032 (IN $ MILLION)
TABLE 23: EUROPE EYELID SURGERY BLEPHAROPLASTY MARKET, BY END-USER, 2024-2032 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC EYELID SURGERY BLEPHAROPLASTY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC EYELID SURGERY BLEPHAROPLASTY MARKET, BY GENDER, 2024-2032 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC EYELID SURGERY BLEPHAROPLASTY MARKET, BY PROCEDURE TYPE, 2024-2032 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC EYELID SURGERY BLEPHAROPLASTY MARKET, BY PRODUCT TYPE, 2024-2032 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC EYELID SURGERY BLEPHAROPLASTY MARKET, BY END-USER, 2024-2032 (IN $ MILLION)
TABLE 29: LATIN AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 30: LATIN AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY GENDER, 2024-2032 (IN $ MILLION)
TABLE 31: LATIN AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY PROCEDURE TYPE, 2024-2032 (IN $ MILLION)
TABLE 32: LATIN AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY PRODUCT TYPE, 2024-2032 (IN $ MILLION)
TABLE 33: LATIN AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY END-USER, 2024-2032 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY GENDER, 2024-2032 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY PROCEDURE TYPE, 2024-2032 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY PRODUCT TYPE, 2024-2032 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET, BY END-USER, 2024-2032 (IN $ MILLION)









LIST OF FIGURES:
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: SUPPLY CHAIN ANALYSIS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY GENDER, 2023 & 2032 (IN %)
FIGURE 5: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY MALE, 2024-2032 (IN $ MILLION)
FIGURE 6: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY FEMALE, 2024-2032 (IN $ MILLION)
FIGURE 7: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY PROCEDURE TYPE, 2023 & 2032 (IN %)
FIGURE 8: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY UPPER EYELID BLEPHAROPLASTY, 2024-2032 (IN $ MILLION)
FIGURE 9: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY COMBINATION EYELID SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 10: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY LOWER EYELID BLEPHAROPLASTY, 2024-2032 (IN $ MILLION)
FIGURE 11: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY PRODUCT TYPE, 2023 & 2032 (IN %)
FIGURE 12: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY LASER SHIELD, 2024-2032 (IN $ MILLION)
FIGURE 13: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY LASER INSTRUMENT, 2024-2032 (IN $ MILLION)
FIGURE 14: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY SURGICAL INSTRUMENT, 2024-2032 (IN $ MILLION)
FIGURE 15: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY END-USER, 2023 & 2032 (IN %)
FIGURE 16: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY HOSPITAL, 2024-2032 (IN $ MILLION)
FIGURE 17: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY CLINICS, 2024-2032 (IN $ MILLION)
FIGURE 18: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY AMBULATORY SURGICAL CENTRE, 2024-2032 (IN $ MILLION)
FIGURE 19: GLOBAL EYELID SURGERY BLEPHAROPLASTY MARKET, BY REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE 20: UNITED STATES EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 21: CANADA EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 22: UNITED KINGDOM EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 23: GERMANY EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 24: FRANCE EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 25: SPAIN EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 26: ITALY EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 27: POLAND EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 28: REST OF EUROPE EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 29: CHINA EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 30: JAPAN EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 31: INDIA EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 32: SOUTH KOREA EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 33: ASEAN COUNTRIES EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 34: AUSTRALIA & NEW ZEALAND EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 35: REST OF ASIA-PACIFIC EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 36: BRAZIL EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 37: MEXICO EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 38: REST OF LATIN AMERICA EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 39: UNITED ARAB EMIRATES EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 40: SAUDI ARABIA EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 41: ISRAEL EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 42: SOUTH AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)
FIGURE 43: REST OF MIDDLE EAST & AFRICA EYELID SURGERY BLEPHAROPLASTY MARKET 2024-2032 (IN $ MILLION)